These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 28204996)

  • 1. Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.
    Song SJ; Min J; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
    Support Care Cancer; 2017 Jul; 25(7):2241-2248. PubMed ID: 28204996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer.
    Schneider BP; Zhao F; Ballinger TJ; Garcia SF; Shen F; Virani S; Cella D; Bales C; Jiang G; Hayes L; Miller N; Srinivasiah J; Stringer-Reasor EM; Chitalia A; Davis AA; Makower DF; Incorvati J; Simon MA; Mitchell EP; DeMichele A; Miller KD; Sparano JA; Wagner LI; Wolff AC
    J Clin Oncol; 2024 Aug; 42(24):2899-2907. PubMed ID: 38828938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study.
    Zhai J; Sun X; Zhao F; Pan B; Li H; Lv Z; Cao M; Zhao J; Mo H; Ma F; Xu B
    Breast; 2023 Feb; 67():36-45. PubMed ID: 36586272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent taxane-induced neuropathy in elderly patients treated for localized breast cancer.
    Pabst L; Velten M; Fischbach C; Kalish M; Pflumio C; Pivot X; Petit T
    Breast J; 2020 Dec; 26(12):2376-2382. PubMed ID: 33307596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taxane-induced peripheral neuropathy and quality of life in breast cancer patients.
    Salehifar E; Janbabaei G; Alipour A; Tabrizi N; Avan R
    J Oncol Pharm Pract; 2020 Sep; 26(6):1421-1428. PubMed ID: 31937190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taxane-Induced Peripheral Neuropathy: Objective and Subjective Comparison Between Paclitaxel and Docetaxel in Patients With Breast Cancer.
    Chan YN; Jheng YW; Wang PJ; Chen CY; Lin MW; Wang YJ
    Clin J Oncol Nurs; 2019 Oct; 23(5):494-501. PubMed ID: 31538967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxane-induced neuropathy: How serious is this problem for patients with early breast cancer?
    Nicolae R; Uccellini A; Siderov J; Mellerick A; Wong V; Yeo B
    Asia Pac J Clin Oncol; 2023 Apr; 19(2):e118-e127. PubMed ID: 35692105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Tolerability of Nab-paclitaxel in Younger versus Elderly Patients With Metastatic HR-positive/HER2-negative Breast Cancer: Results From the Noninterventional, Prospective Study NABUCCO.
    Potthoff K; Stötzer O; Söling U; Hansen R; Harde J; Dille S; Nusch A; Marschner N
    Clin Breast Cancer; 2020 Jun; 20(3):e315-e326. PubMed ID: 32273207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol.
    Sharma A; Johnson KB; Bie B; Rhoades EE; Sen A; Kida Y; Hockings J; Gatta A; Davenport J; Arcangelini C; Ritzu J; DeVecchio J; Hughen R; Wei M; Thomas Budd G; Lynn Henry N; Eng C; Foss J; Rotroff DM
    Technol Cancer Res Treat; 2022; 21():15330338221127169. PubMed ID: 36172750
    [No Abstract]   [Full Text] [Related]  

  • 10. Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment.
    Tamburin S; Park SB; Alberti P; Demichelis C; Schenone A; Argyriou AA
    J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S40-S51. PubMed ID: 31647157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial.
    Shimozuma K; Ohashi Y; Takeuchi A; Aranishi T; Morita S; Kuroi K; Ohsumi S; Makino H; Katsumata N; Kuranami M; Suemasu K; Watanabe T; Hausheer FH
    Support Care Cancer; 2012 Dec; 20(12):3355-64. PubMed ID: 22584733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term peripheral neuropathy symptoms in breast cancer survivors.
    Mustafa Ali M; Moeller M; Rybicki L; Moore HCF
    Breast Cancer Res Treat; 2017 Nov; 166(2):519-526. PubMed ID: 28791499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of persistent peripheral neuropathy on health-related quality of life among early-stage breast cancer survivors: a population-based cross-sectional study.
    Engvall K; Gréen H; Fredrikson M; Lagerlund M; Lewin F; Åvall-Lundqvist E
    Breast Cancer Res Treat; 2022 Oct; 195(3):379-391. PubMed ID: 35941422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer-a systematic review.
    Fernandes R; Mazzarello S; Hutton B; Shorr R; Majeed H; Ibrahim MF; Jacobs C; Ong M; Clemons M
    Support Care Cancer; 2016 Aug; 24(8):3633-50. PubMed ID: 27146496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for taxane-induced peripheral neuropathy in patients with breast cancer.
    Liang C; Zhang Y; Chen QY; Chen WF; Chen MZ
    Asia Pac J Clin Oncol; 2024 Apr; 20(2):220-227. PubMed ID: 36658674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans.
    Schneider BP; Lai D; Shen F; Jiang G; Radovich M; Li L; Gardner L; Miller KD; O'Neill A; Sparano JA; Xue G; Foroud T; Sledge GW
    Oncotarget; 2016 Dec; 7(50):82244-82253. PubMed ID: 27732968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality-of-life considerations with taxane-based therapy in metastatic breast cancer.
    Maxwell C
    Clin J Oncol Nurs; 2013 Feb; 17 Suppl():35-40. PubMed ID: 23360701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the traditional Chinese medicine, Buyang Huanwu Decoction, at preventing taxane-induced peripheral neuropathy in breast cancer patients: A prospective, randomized, controlled study.
    Luo F; Wan D; Liu J; Chen D; Yuan M; Zhang C; Liu Q
    Medicine (Baltimore); 2024 Mar; 103(9):e37338. PubMed ID: 38428887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence density and factors associated with peripheral neuropathy among women with breast cancer during taxane-based chemotherapy.
    Rattanakrong N; Siriphorn A; Boonyong S
    Sci Rep; 2022 Jun; 12(1):10632. PubMed ID: 35739233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current methods for the assessment and management of taxane-related neuropathy.
    Smith EM
    Clin J Oncol Nurs; 2013 Feb; 17 Suppl():22-34. PubMed ID: 23360700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.